1Giamarellou H,Antoniadou A.Antipseudomonal antibiotics[J].Med Clin North Amer,2001,85(1):19-42.
2Trouillet J L,Vuagnat A,Combes A,et al.Pseudomonas aeruginosa ventilator-associated pneumonia:Comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms[J].Clin Infect Dis,2002,34:1047-1054.
3Cavallo J D,Fabre R,Garrabe E.Which betalactam antibiotic use as a marker of multiresistance in Pseudomonas aeruginosa[J].Pathol Biol (Paris),2003,51(8-9):460-463.
4Regal R E,DePestel D D,VandenBussche H L.The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to β-Lactams in a large teaching hospital[J].Pharmacotherapy,2003,23(5):618-624.
5Yildirim S,Zafer T N,Tarim A,et al.Bacteriological profile and antibiotic resistance:Comparison of findings in a burn intensive care unit,other intensive care units,and the hospital services unit of a single center[J].J Burn Care and Rehabilitation,26(6):488-492.
8Livermore D M.Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:Our worst nightmare[J].Clin Infect Dis,2002,34(1 Mar):634-640.
9Hanberger H,Garcia-Rodriguez J A,Gobernado M,et al.Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries[J].JAMA,1999,281:67-71.
10Lepper P M,Grusa E,Reichl H.Consumption of imipenem correlates with β-Lactam resistance in Pseudomonas aeruginosa[J].Antimicrobial Agents and Chemotherapy,2002,2920-2925.
3[1]Kloos WE, Bannerman TL. Staphylococcus and Micrococcus[A]. In:Murray PR,Baron EJ, Pfaller MA, et al. In mannual of Clinical microbiology, 7th ed[M]. Washington DC. 1999. 264-282
4[2]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. 11th inform supplements. M2-A6 and M7-A4. Wayne, Pa: National Committee for Clinical Laboratory Standards. 2001,23-52
6[4]Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacterienia: outcome correlations in a prospective study of 200 patients[J]. Am J Med, 1989,87: 540-546
7[5]Larson EL. Persistent carriage of gram-negative bacteria on hands [J]. Am J Infect Control, 1981,9:112-119
8Itokazu GS, Quinn JP, Bell-Dixon C, et al. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive-care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis, 1996, 23: 779-784.
10Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Psedomonas aeruginosa bacteriemia: outcome correlations in a prospective study of 200 patients. Am J Med, 1989, 87:540-546.
